Biomerica, Inc.
BMRANASDAQHealthcare● Active
$2.07
$-0.05(-2.36%)
Market Cap$6396857
P/E Ratio—
52W High$4.6
52W Low$1.87
Biomerica, Inc. (BMRA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BMRA · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-05 | 2024-05 | 2023-05 | 2022-05 | 2021-05 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $5.31M | $5.42M | $5.34M | $18.87M | $7.20M |
| Cost of Revenue | $4.81M | $4.80M | $4.89M | $15.89M | $6.83M |
| Gross Profit | $0.50M | $0.61M | $0.45M | $2.98M | $0.37M |
| Gross Margin %(computed) | 9.38% | 11.28% | 8.35% | 15.78% | 5.09% |
| Operating Expenses | |||||
| R&D Expenses | $1.02M | $1.49M | $1.58M | $1.81M | $2.19M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $5.63M | $6.98M | $7.67M | $7.51M | $7.87M |
| Operating Income | ($5.14M) | ($6.37M) | ($7.22M) | ($4.53M) | ($7.50M) |
| Operating Margin %(computed) | -96.72% | -117.58% | -135.29% | -24.03% | -104.18% |
| Interest Income | $0.17M | $0.43M | $0.13M | $0.03M | $0.07M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($4.97M) | ($5.94M) | ($7.09M) | ($4.51M) | ($7.43M) |
| Income Tax Expense | $0.00M | $0.04M | $0.05M | $0.02M | $0.01M |
| Net Income | ($4.97M) | ($5.98M) | ($7.14M) | ($4.53M) | ($7.45M) |
| Net Margin %(computed) | -93.64% | -110.40% | -133.73% | -24.01% | -103.43% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.16 | $-0.36 | $-0.50 | $-0.36 | $-0.54 |
| Wtd Avg Shares | 2.30M | 16.82M | 14.15M | 12.67M | 11.93M |
| EBITDA | ($4.74M) | ($5.99M) | ($6.87M) | ($3.94M) | ($7.06M) |
| EBITDA Margin %(computed) | -89.19% | -110.67% | -128.71% | -20.87% | -98.03% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Biomerica, Inc. data
About Biomerica, Inc. (BMRA) Income Statement
Biomerica, Inc. (BMRA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BMRA reported revenue of $0.01B, gross profit of $0.00B (gross margin 9.38%), and net income of ($0.00B) — a net profit margin of -93.64%.
Frequently asked questions
BMRA · 4 questionsBiomerica, Inc. (BMRA) reported revenue of $0.01B for 2025, down 1.9% year-over-year.
BMRA revenueBMRA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08